Rat neutrophil activation and effects of lipoxygenase and cyclooxygenase inhibitors.
about
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) familyWalker carcinosarcoma cells damage endothelial cells by the generation of reactive oxygen species.Mediators of lung injury in mice following systemic activation of complement.In vitro activation of rat neutrophils and alveolar macrophages with IgA and IgG immune complexes. Implications for immune complex-induced lung injury.Activated rat neutrophils. Correlation of arachidonate products with enzyme secretion but not with O(2)- generation.Modulation of acute immune complex-mediated tissue injury by the presence of polyionic substances.A Review on the Medicinal Plant Dalbergia odorifera Species: Phytochemistry and Biological Activity.
P2860
Q24652940-64E9E969-E684-47AA-9800-7153550CA76AQ35816590-0625A205-6A64-4D18-98FB-FD133A0DEC61Q35835559-06B5D762-7CB4-4959-A37B-240725CE013FQ35856577-8BB7BE19-F4AF-45E2-9C8A-83FC7302BDCBQ42103705-2F65597D-51EB-4D2B-9042-46E67CBBBE6AQ42738186-15DA3588-E24C-4609-892D-215B6F876B2CQ48214506-A4893804-F2A9-4FDC-8327-531BD5018EDC
P2860
Rat neutrophil activation and effects of lipoxygenase and cyclooxygenase inhibitors.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Rat neutrophil activation and effects of lipoxygenase and cyclooxygenase inhibitors.
@ast
Rat neutrophil activation and effects of lipoxygenase and cyclooxygenase inhibitors.
@en
type
label
Rat neutrophil activation and effects of lipoxygenase and cyclooxygenase inhibitors.
@ast
Rat neutrophil activation and effects of lipoxygenase and cyclooxygenase inhibitors.
@en
prefLabel
Rat neutrophil activation and effects of lipoxygenase and cyclooxygenase inhibitors.
@ast
Rat neutrophil activation and effects of lipoxygenase and cyclooxygenase inhibitors.
@en
P2093
P2860
P1476
Rat neutrophil activation and effects of lipoxygenase and cyclooxygenase inhibitors.
@en
P2093
K J Johnson
M C Sulavik
P2860
P304
P407
P577
1984-08-01T00:00:00Z